NEW YORK (GenomeWeb News) — Diagnostics technologies developer Avacta Group and the University of Liverpool will collaborate to develop integrated microarray and mass spectrometry tools for use in detecting biomarkers and discovering new drug targets.

Wetherby, UK-based Avacta said today the partners will combine the firm's engineered affinity reagent microarrays, which it calls Affimer microarrays, and reagents with mass spectrometry tools developed by University of Liverpool Professor Rob Beynon.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.

May
01
Sponsored by
Horizon Discovery

This webinar will provide an in-depth case study demonstrating how reference standards can be used to develop and validate circulating tumor DNA (ctDNA)-based assays.

May
08
Sponsored by
Dovetail Genomics

This webinar will discuss a proximity ligation-based method for studying structural variation in formalin-fixed paraffin-embedded (FFPE) tissue.